● LIVE
NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40
Login☆ Watchlist
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommoditiesIPOs
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingStartupsEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth

SYNGENE

BSE
Syngene International Limited
Healthcare· Healthcare Services· INE398R01022· Scrip: 539268
ENहिन्दीગુજરાતીमराठी
454.70
10.30 (+0.00%)
2026-06-10
BSE
454.70
10.30
+0.00%
38947355764172606-1608-0710-0311-2801-2303-2005-2506-10
233 trading days · 1Y period
TODAY (BSE)
Open445.50
High462.00
Low445.50
Prev Close444.40
Volume88,309
Value₹4.0Cr
L: 445.50H: 462.00
Info
Face Value₹10
Listed2015-08-11
ISININE398R01022
SeriesA
BSE Scrip539268

Key Metrics

1D
1W
1M
3M
6M
Growth (QoQ)
Revenue+5.91%
PAT+23.56%
EPS+23.86%
Profitability
Dividend
Latest DPS₹1.25
Growth+0.00%
TTM Revenue
₹3478 Cr
TTM EBITDA
₹1188 Cr
TTM PAT
₹500 Cr
TTM EPS
₹12.45
Rev/Share
₹86.3

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr249 Cr497 Cr746 Cr994 Cr22-1223-0323-0923-1224-0324-0624-0924-122.74.52.92.84.71.82.63.3
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31944 Cr781 Cr352 Cr181 Cr131 Cr3.27
2024-09-30891 Cr770 Cr293 Cr137 Cr106 Cr2.64
2024-06-30727 Cr677 Cr191 Cr99 Cr74 Cr1.84
2024-03-31917 Cr724 Cr353 Cr209 Cr189 Cr4.70
2023-12-31854 Cr741 Cr284 Cr138 Cr112 Cr2.78
2023-09-30910 Cr774 Cr303 Cr151 Cr117 Cr2.90
2023-03-31994 Cr786 Cr389 Cr231 Cr179 Cr4.46
2022-12-31786 Cr663 Cr278 Cr140 Cr110 Cr2.74

Shareholding Pattern

CURRENT2026-03-31
52.7%PROMOTER
Promoter52.7%
FII13.9%
DII26.4%
Public47.0%
PROMOTER HOLDING TREND
54.7%24-0654.7%24-0952.7%24-1252.7%25-0352.7%25-0952.7%25-1252.7%26-03

Corporate Actions

Ex-DateTypePurpose
2026-06-25DividendDividend - Rs 1.25 Per Share
2025-06-27DividendDividend - Rs 1.25 Per Share
2024-06-28DividendDividend - Rs 1.25 Per Share
2023-06-30DividendDividend - Rs 0.50 Per Share/Special Dividend - Rs 0.75 Per Share
2022-06-30DividendDividend - Rs 0.50 Per Share/Special Dividend - Rs 0.50 Per Share
2021-07-13Other Annual General Meeting
2019-07-16Dividend Dividend - Rs 0.50 Per Share
2019-06-11Bonus Bonus 1:1
2018-07-17Dividend Dividend Re - Re 1 Per Share
2017-07-20Dividend Dividend - Rs 1/- Per Share
2016-03-17Dividend Interim Dividend - Re 1/- Per Share (Purpose Revised)

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-06-10446.60462.15446.20454.6515.32L
2026-06-03444.00444.00432.15438.103.19L
2026-05-27467.90467.90459.00460.4012.79L
2026-05-26463.00472.75463.00465.253.83L
2026-05-25467.00472.00458.45462.408.78L
2026-05-22471.95472.15460.25461.854.77L
2026-05-21473.00473.80464.35470.203.70L
2026-05-20471.10475.20461.75466.056.15L
2026-05-19466.45479.10461.25471.3512.86L
2026-05-18454.80469.55453.75466.3012.66L
2026-05-15472.75472.75452.50454.0510.05L
2026-05-14466.95485.10464.10467.9513.84L
2026-05-13478.00478.75462.00463.257.51L
2026-05-12486.25486.25470.00478.7521.71L
2026-05-11455.00490.70453.40482.5051.31L
2026-05-08466.60469.90456.15458.106.50L
2026-05-07454.00477.00450.15467.3549.28L
2026-05-06455.95459.55439.50450.1025.90L
2026-05-05480.85480.85449.10451.4029.01L
2026-05-04467.35492.25453.60477.3543.50L
2026-04-30431.95518.55429.90467.655.93Cr
2026-04-29440.25443.95429.90432.156.31L
2026-04-28435.00445.60434.10440.258.17L
2026-04-27423.00440.90421.25437.956.48L
2026-04-24430.00432.55417.45421.206.48L
2026-04-23431.00442.40427.00428.358.49L
2026-04-22448.00449.70430.00435.957.44L
2026-04-21436.00450.95434.85444.659.98L
2026-04-20440.00443.50433.15436.454.46L
2026-04-17438.90441.50430.80436.605.39L

Frequently Asked Questions

About

Syngene International Limited, listed on the National Stock Exchange of India (NSE) as SYNGENE, is a prominent contract research and manufacturing company specializing in drug discovery and development services with operations spanning India, the United States, Europe, and internationally. The company offers key services including custom screening, fragment-based drug design, and cell and gene therapy solutions, catering to the pharmaceutical and biotechnology industries. Founded in 2000, Syngene has established itself as a leading player in the CDMO (Contract Development and Manufacturing Organization) space, serving clients globally with its innovative and scalable service model.

BOARD OF DIRECTORS
Carl Decicco
Executive Director
DEPARTED
Sibaji Biswas
Executive Director
DEPARTED
Vinita Bali
Executive Director
Manja Boerman
Independent Director
Nilanjan Roy
Independent Director
Sharmila Abhay Karve
Independent Director

Mutual Fund Holdings

3 funds · bar length = % to NAVBrowse all funds →
hdfc2 schemes
HDFC NIFTY SMALLCAP 250 INDEX FUND
0.45%
₹2 Cr
HDFC Large and Mid Cap Fund
0.09%
₹23 Cr
dsp1 scheme
DSP Regular Savings Fund
0.00%
₹1 Cr